AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03852134 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DCC Group
Description: The OB provider will hold the baby at or below the level of placenta, provide warmth, stimulate the baby to breathe and suction the mouth/nose if needed for the first 30 seconds.~After these initial 30 seconds, if the baby is breathing then the obstetrician will continue DCC for a total of 60 seconds before clamping and cutting the cord close to the umbilicus and handing over the baby to the neonatal team for further stabilization as per standard NRP practice. If the baby is not breathing after the initial 30 seconds of DCC, then the OB provider will clamp and cut the cord close to the umbilicus and hand over the baby to the neonatal team to continue resuscitation of the baby as per the standard NRP guidelines.
Study NCT03043885 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FDBA
Description: Graft material used to graft extraction socket
Study NCT03043885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FDBA
Description: Graft material used to graft extraction socket
Study NCT03043885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRF
Description: Autologous blood product used to graft extraction socket
Study NCT03043885 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood Clot
Description: Surgical treatment of extraction socket without addition of graft material
Study NCT04071197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gastostomy-biliary tube
Description: gastrostomy followed by ERCP with nasobiliary stent placement in the CBD with its distal end been exit from the previously performed gastrostomy instead of the nostril
Study NCT04071197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: External biliary diversion, internal biliary diversion and nasobiliary tube
Description: All biliary diversion modalities other than gastrobiliary tube
Study NCT03164811 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: goal directed fluid therapy
Description: pulse pressure variation will be used to as a goal to guide fluid administration in this group
Study NCT03164811 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Controlled
Description: standard fluid treatment by an anesthesiologist
Study NCT03553758 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Subjects' brain waves will be monitored by EEG recording under ketamine general anesthesia over the course of approximately 60 minutes. Patients pain and dissociation will be assessed before the induction of ketamine and periodically after. Approximately 1 hour after ketamine induction, Midazolam will be administered to reduce patient dissociation.
Study NCT03210207 — intervention group
Intervention type: PROCEDURE
Intervention: GASTROPLICATURE
Description: All procedures were performed by a single surgeon. All patients underwent 2-row gastric plication. Dissection was started at the greater curvature of the stomach in contact to the gastric wall from prepyloric area to 2-cm proximal to the Hiss angle preserving the anatomy of Hiss angle. All vessels along the greater curvature were separated using LigaSure (Covidien, Mansfield, MA, USA). The greater curvature (from the perimeter) was invaginated using 2 rows of 00 prolene or 00 nylon sutures. Two layers of plication were performed with continuous sutures with 1 surgical sting in all patients to prevent any displacement of inverted folds such as eversion outside or intussusception into esophagus or pylorus. All sutures were extramucusal to avoid their absorption by gastric acid. Finally, a tube shaped stomach was achieved in which the greater curvature was inverted in to the stomach.
Study NCT04657471 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: revised HOME-CoV score
Description: Educational lectures, posters, and pocket cards showing and explaining the revised HOME-CoV score are communicated to participating Emergency Departments.~For included patients, the physician-in-charge calculates the revised HOME-CoV. Patients with a score \<2 qualified for home treatment. They qualified otherwise for hospitalization. For patients with a score > 4, hospitalization in a unit allowing monitoring of vital parameters is recommended. However, the physician-in-charge can overrule the qualification for home treatment or for hospitalization in case of major medical or social reasons. A justification explaining the cause of overruling is required.
Study NCT04260893 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tixel
Description: Peri-Orbital fractional treatment on the Eye-Lid to assess the effect on Dry Eye symptoms
Study NCT00239239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Description: darbepoetin alfa SC dosing 0.45 mcg/kg 3 times per week through study day 40. Optional extended treatment period: 200 mcg Q2W through study day 110
Study NCT02448277 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Macintosh Laryngoscope
Description: the device is to assist nasotracheal intubation
Study NCT02448277 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pentax Airway scope
Description: the device is to assist the nasotracheal tube into trachea
Study NCT02448277 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Glidescope
Description: the device is to assist the nasotracheal tube into trachea
Study NCT01847300 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cSBI-M
Description: In cSBI-M participants complete a computerized screen for alcohol and tobacco use and then view 10 pages describing the health effects of substance use and true life stories of those affected by substance use.
Study NCT02684448 — intervention group
Intervention type: PROCEDURE
Intervention: Inguinal Hernia Repair
Description: Inguinal (unilateral or bilateral) hernia repair
Study NCT01875159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine citrate 6 mg/kg/day
Description: Comparison of caffeine citrate 6 mg/kg/day versus no caffeine (usual care) on extent of intermittent hypoxia at 35, 36, 37, 38, 39, and 40 weeks postmenstrual age.
Study NCT03779542 — intervention group
Intervention type: PROCEDURE
Intervention: cataract surgery
Description: phacoemulsification and intraocular lens implantation
Study NCT01538069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: It consisted of three sessions/week, on non-consecutive days. The aerobic protocol consisted of a warm-up (strengthening exercises, 10 minutes), aerobic exercise (30 minutes in the first month and 45 minutes in the last two months) and cool-down (strengthening exercises, 10 minutes). The aerobic exercise intensity was established by heart rate levels that corresponded to anaerobic threshold, 10 heart rates down and 10 heart rates up, assessed by cardiopulmonary exercise testing. The strength training consisted of eight exercises attending the major muscle groups and the intensity was determined by 50-60% of one-repetition maximum (1-RM) and the progression of the training will be monthly: first month (a series of 12 repetitions with 50% 1-RM), second month (1 set of 15 repetitions with 60% 1-RM) and third months (2 sets of 10 repetitions with 60% 1-RM).
Study NCT01538069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CPAP group
Description: The CPAP treatment will be according to protocol of the Department of Psychobiology. Titration will be perform after randomization with ventilation device servo-assisted so as to ensure positive pressure within the first 24 hours of treatment. The treatment will be for three months.
Study NCT01538069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and CPAP group
Description: The patients randomized for this group will perform both Exercise protocol and CPAP treatment at the same time for three months.
Study NCT03462108 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotavirus (Bio Farma) Vaccine
Description: Rotavirus (Bio Farma) Vaccine
Study NCT03462108 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo contains 30% sucrose in DMEM
Study NCT02921672 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean Diet
Description: Diet consisting of fruits, vegetables, grains, dairy, olive oils, seafood, and nuts. It is low in red meat and solid fats.
Study NCT02921672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet
Description: Diet consisting of fruits, vegetables, grains, dairy, olive oils, seafood, and nuts. It is low in red meat and solid fats.
Study NCT01389882 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: neurally adjusted ventilatory assist (NAVA) ventilator mode
Description: Neurally adjusted ventilatory assist (NAVA) utilizes the electrical activity of the diaphragm (EAdi) to trigger and cycle-off breaths, and therefore presents a means of bypassing the ventilator circuit, and the inherent delays with pneumatic triggering. This is a processed signal, which is not artificially influenced by changes in muscle length, chest wall configuration, and/or lung volume. It represents the summation of muscle motor unit recruitment and/or firing rate, and correlates with phrenic nerve activity. In this mode, the amount of support pressure is coupled with the magnitude of the EAdi. The proportion of support pressure to EAdi (NAVA level) is adjustable.
Study NCT04589858 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Supervised exercise protocol
Description: Strengthening exercises:It included a sets/group of exercises such as a static quad set in knee extension, standing terminal knee extension, seated leg-press, partial squats weight-lessened with arm support as needed, and step-ups Stretching Exercises:A slow, sustained stretching was performed in different positions for different group of muscles with holding time 30-seconds, a gap of 1-minute between two repetitions, and repeated 3-times per session on alternate day for 2-weeks. The stretching performed for the calf muscle, hamstring muscle, and quadriceps femoris muscle in standing, supine, and prone positions respectively.
Study NCT04589858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised exercise protocol
Description: Strengthening exercises:It included a sets/group of exercises such as a static quad set in knee extension, standing terminal knee extension, seated leg-press, partial squats weight-lessened with arm support as needed, and step-ups Stretching Exercises:A slow, sustained stretching was performed in different positions for different group of muscles with holding time 30-seconds, a gap of 1-minute between two repetitions, and repeated 3-times per session on alternate day for 2-weeks. The stretching performed for the calf muscle, hamstring muscle, and quadriceps femoris muscle in standing, supine, and prone positions respectively.
Study NCT04589858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specified Manual Therapies
Description: Myofascial Mobilization: Patellar glide performed in all available ROM and direction such as superior-inferior and lateral-medial translation/glides of patella over patellar fossa.~Myofascial manipulation technique: Manipulation of knee joint. An impulse type thrust was delivered, directed in the caudal direction to mobilize the joint in a near-full extension position.
Study NCT00436995 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Darbepoetin Alfa
Description: Administered IV or SC, Q2W at the following unit doses: 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 200 or 300ug. Initial Q2W dose calculated from pre-enrollment QW doses. Doses titrated to achieve target Hb.
Study NCT02539797 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tDCS
Description: comparing anodal, cathodal, and sham tDCS
Study NCT02539797 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: comparing anodal, cathodal, and sham tDCS
Study NCT02539797 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: comparing anodal, cathodal, and sham tDCS
Study NCT02762695 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Case Management
Description: A model of health care for chronic patients, based on Case Management and guided by a nurse which targets the patient´s risk.~The core elements of this strategy are: a. processes to identify specific population and their risk; b. evidence-based practice guidelines according to risk (higher risk, more interventions and monitoring by a nurse, lower risk, higher emphasis on self-care); c. Practice models based on collaboration between health team members leaded by a nurse; d. self-management education for patients; e. monitoring patients face to face or by telephone to ensure to follow the care program (blood test, medical consultation, for example); e. measurement of process and outcomes.
Study NCT02762695 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual Care at Primary Health Care Center
Study NCT05721495 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: freeze all strategy embryo transfer
Description: criopreservation of all viable embryos in order to transfere the best one in a posterior cycle
Study NCT05721495 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: fresh embryo transfer strategy
Description: transfer of the best embryo two or three days after the fecundation technique
Study NCT03958175 — intervention group
Intervention type: OTHER
Intervention: Alouette test (reading test)
Description: The alouette test was assessed at a fixed distance of 40 centimeters on a fixed surface to avoid errors related to hand tremors.
Study NCT03430791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab 240 mg IV
Description: Nivolumab IV 240mg IV every 2 weeks for maximum of 24 months.
Study NCT03430791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg
Description: Nivolumab IV 3mg/kg every 2 weeks for maximum of 24 months.
Study NCT03430791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab 1 mg/kg
Description: Ipilimumab IV 1 mg/kg every 6 weeks for maximum of 4 doses.
Study NCT03430791 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NovoTTF200A (Optune)
Description: A device to be worn continuously for a goal of 75% of the time, ranging from 18 hours daily nonstop or 22 hours daily with 2-3 days off monthly.
Study NCT02016976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EMLA Analgesic Cream
Study NCT02016976 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dormicum 2.5 mg and Pethidine 25 mg
Description: Routine anesthesia and analgesia ( Dormicum 2.5 mg and Pethidine 25 mg )normally given to patients before and during pacemaker implantation
Study NCT02937337 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laryngeal mask insertion with videostylet guided technique
Study NCT02937337 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal mask insertion with standard blind technique
Study NCT01390896 — intervention group
Intervention type: DRUG
Intervention: Fondaparinux Sodium
Study NCT01909895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anger Induction
Description: The participant is asked to recall an incident in the recent past during which they became moderately to extremely angry, or is asked to read statements out loud evoking moderate to extreme feelings of anger. The participant is asked to take a few moments to bring the details of the incident to mind and, when ready, to describe the incident in great detail to the experimenter. Participants are asked to describe key elements, such as any dialogue that transpired during the incident, along with other details of the incident, particularly regarding the feelings of that particular emotion experienced at the time. In so doing, the experimenter works to re-elicit the emotions that accompanied the original incident. The duration of the negative emotion induction task is 8 minutes.
Study NCT01909895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Depressed Mood Induction
Description: The participant will be asked to undergo a validated depression/sadness induction task.
Study NCT01909895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anxiety Induction
Description: The participant will be asked to undergo a validated anxiety induction task.
Study NCT01909895 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neutral emotion task
Description: This is a neutral control task that each of the negation emotion induction tasks will be compared to.
Study NCT01493193 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Endurance training with constant work load
Description: Endurance training with constant work load(n=15): 31min at 65-75% HRmax
Study NCT01493193 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pyramid-Training
Description: Pyramid-Training (n=15): One Pyramid consists of 8 one-minute blocks. Those are grouped starting with one block of 70-75% HRmax, followed by one block at 75-80% HRmax and another one at 80-85% HRmax. The top of the pyramid are 2 blocks of 85-90% HRmax. Intensity is lowered afterwards with one block at 80-85% HRmax, followed by one block at 75-80% HRmax and last one at 70-75% HRmax. Two more pyramids follow, each divided by 2min of active recovery at 65-70% HRmax, making it a total of 28min.
Study NCT01493193 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: HIT (n=15): 4x4min intervals at 85-95% HRmax divided by 3x3min of active recovery at 60-70% HRmax, making it a total of 25min
Study NCT00633971 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: complex lymphedema therapy
Description: Patients with established post thrombotic syndrome will be randomized to either compression stocking use or complex lymphedema therapy.
Study NCT00633971 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: complex lymphedema therapy
Description: Patients with established post thrombotic syndrome will be randomized to either compression stocking use or complex lymphedema therapy.
Study NCT04543773 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS
Description: rTMS will be delivered to the fMRI-determined DLPFC hotspot according to conventional parameters for clinical treatment (e.g., excitatory: 75 trains of 40 pulses, 10Hz, up to 3000 pulses). Magnetic field strength will be up to 120% of resting motor threshold. Ramp up of magnetic field strength may be utilized in the first week for tolerability. Side effects will be monitored and coil angle adjusted to improve tolerability if necessary.
Study NCT02981368 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-DCFPyL Injection
Description: A single dose of 9±1 mCi (333±37 MBq) IV injection of 18F-DCFPyL
Study NCT02981368 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/CT imaging
Description: PET/CT imaging will be acquired 1-2 hours post-PyL injection
Study NCT04360746 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pharmaceutical intervention
Description: Pharmaceutical intervention will include a complete medication review by a clinical pharmacist with the following process: medication reconciliation, medication indication and dosage check, medication effectiveness and appropriateness assessment, drug-drug or drug-disease interactions check, medication duplications check, length and cost of treatment evaluation. The pharmacist will use the following tools: Medication appropriateness index (MAI), ACB (Anticholinergic cognitive burden) score and the using the assessment of underutilization (AOU) index.
Study NCT04360746 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: A multidisciplinary team provided medical, nursing, physical, occupational, and social work interventions. Rehabilitation care include: (a) individual physical therapy (PT), 2 to 3 times a week; (b) 30 to 40 min of PT in an adapted fitness room, aerobic training on a treadmill with and without partial weight support and stationary bicycles, 2 to 3 times a week ; (c) 30 to 40 min of virtual reality training by performing challenging functional tasks, 2 times a week and (d) 30 to 45 min of individual occupational therapy (OT), cognitive evaluation and stimulation, safety education, and learning to use assistive devices, 3 times a week.
Study NCT04360746 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Rehabilitation
Description: A multidisciplinary team provided medical, nursing, physical, occupational, and social work interventions. Rehabilitation care include: (a) individual physical therapy (PT), 2 to 3 times a week; (b) 30 to 40 min of PT in an adapted fitness room, aerobic training on a treadmill with and without partial weight support and stationary bicycles, 2 to 3 times a week ; (c) 30 to 40 min of virtual reality training by performing challenging functional tasks, 2 times a week and (d) 30 to 45 min of individual occupational therapy (OT), cognitive evaluation and stimulation, safety education, and learning to use assistive devices, 3 times a week.
Study NCT03902691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegol-Sihematide
Description: Participants received Pegol-Sihematide by subcutaneous injection once every 4 weeks ; the dose was adjusted throughout the study to maintain a hemoglobin target range of 10.0-12.0 grams per deciliter (g/dL).
Study NCT03902691 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ESPO
Description: Participants received ESPO by subcutaneous injection or subcutaneous injection weekly. The dose was adjusted throughout the study to maintain a hemoglobin target range of 10.0-12.0 g/dL.
Study NCT04510649 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part A
Description: in Part A, all subjects will receive Surufatinib 300 mg in a single dose on study days 1 and 11 and receive Rabeprazole 30 mg single dose on study days 5 through 11
Study NCT04510649 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part B
Description: in Part B, all subjects will receive Surufatinib 300 mg in a single dose on study days 1 and 12 and receive Rifampin 600 mg single dose on study days 5 through 16